The human amyloid beta 42 (Hu Abeta 42 US) quantifies human abeta 42 at very low levels in tissue culture media, tissue homogenates, and human cerebrospinal fluid. The dosage...
The human amyloid beta 42 (Hu Abeta 42 US) quantifies human abeta 42 at very low levels in tissue culture media, tissue homogenates, and human cerebrospinal fluid. The dosage will recognize exclusively the natural and recombinant Abeta 42 US Hu. The principle of the L-ELISA (immuno-enzymatic test) solid phase sandwich of human Abêta-42 US is designed to measure the amount of the target bound between a pair of matched antibodies. A target-specific antibody was pre-assembled in the wells of the supplied microplate. Samples, standards or controls are then added to these wells and bind to the immobilized antibody (capture). The sandwich is formed by adding the second antibody (detector), a substrate solution that reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample. Rigorous validation Each batch manufactured from this ELISA kit is tested for quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.
Beta-amyloid is a 40–43 amino acid peptide cleavage of the amyloid precursor protein and a putative gamma-secretase. The amyloid beta (1-40) and the amyloid beta (1-42) are two major C-terminal variants of the amyloid beta protein, making up the majority of the amyloid beta proteins. Alloforms beta amyloids (40) and beta amyloids (42) are major components of extracellular plaques present in the brain tissue of Alzheimer's disease. Order information
Shipping conditions: Wet ice
Measurement range
Dosing range: 1.56-100 pg/ml.
Duration of dosing
Total duration of dosing: 4 hours.
Reproducibility
Coefficient of intra-dose variation 8.6%, inter-dose 7.5%.
Samples
Sample type: Tissue homogenates, Cepha-rachidial liquid, Surnatant (Cephalochidial fluid volume, 25 μl; supernatant, 25 μl; tissue homogenate, 25 μl).
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 10212423 |
| Specifications |
| Accession number | P05067 |
| Dose range | 1.56-100 pg/ml |
| Sensitivity of the dosage | <1 pg/ml |
| Concentration | 1.56 to 100 pg/ml |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Type of sample | Tissue homogenates, Cephal-Rapidian liquid, Surnatant |
| Target species | Human |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 351 |
| Gene symbol(s) | AAA,ABETA,ABPP,AD1I,CTFgamma,CVAP,PN-II,PN2,APP |
| Incubation time | 4 h |
| Coefficient of inter-dose variation | 7.5% |
| Coefficient of intra-dose variation | 8.6% |
| Contents of kits | 96-well pre-coated plate, Streptavidine HRP, HRP diluent, Wash pad, Chromogen, Stop solution, Adhesive plate covers |
| Marker or dye | HRP |
| Genetic marker | Aβ 42 |
| Quantity | 96 tests |
| Regulatory status | RUO |
| Target | Human |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | 25 μl cerebrospinal liquid; supernatant, 25 μl; tissue homogenate, 25 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h |
Origin and customs
| Manufacturer ref. | KHB3544 |
|---|
| Country of origin | Autriche |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.